Page 145 - book

AryoGen Pharmed Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Product List

Type Product Dosage form Strength Indication Status

in 3
different
Lyophilised doses of Congenital hemophilia A or B with inhibitors Ac-
Blood coagula- AryoSeven powder 1.2 mg, quired hemophilia Available in
tion factors Congenital factor VII deficiency the market
in a glass vial 2.4 mg Glanzmann’s thrombasthenia
and 4.8
mg
Congenital hemophilia A or B with inhibitors
Lyophilised
Blood coagula- AryoSevenRT powder 1mg, Acquired hemophilia Available in
tion factors 2mg, 5mg Congenital factor VII deficiency the market
in a glass vial
Glanzmann’s thrombasthenia
Non-Hodgkin’s Lymphoma (NHL)
A vials sterile,
antineoplas- clear and color- Chronic Lymphocytic Leukemia (CLL)
tic agents, Zytux less concentrate 100mg, Rheumatoid Arthritis (RA) Available in
monoclonal for solution for 500mg Granulomatosis with polyangiitis (GPA) and micro- the market
antibodies scopic polyangiitis (MPA)
infusion
Pemphigus vulgaris.
antineoplas- Prefilled syringes doses of
tic agents, Altebrel containing solu- 25 mg treatment of Rheumatoid Arthritis, Psoriasis Ar- Available in
monoclonal tion for injection and 50 thritis and Axial Spondyloarthritis Plaque Psoriasis the market
antibodies for subcutaneous mg

Antineoplas- Lyophilised HER2 over-expressing early breast cancer
tic agents, AryoTrust powder 150mg, HER2 over-expressing metastatic breast cancer Available in
monoclonal in a glass vial 440mg HER2 over-expressing metastatic gastric cancer the market
antibodies

Moderate to severe active rheumatoid arthritis
(RA), active Systemic Juvenile Idiopathic Arthrits
Immunosu- A vial contains 80mg, (sJIA), active Polyarticular Juvenile Idiopathic
pressants, Temziva concentrate for 200mg, Arthritis (pJIA), Cytokine Release Syndrome (CRS), Available in
Interleukin solution for intra- 400mg Treat Cytokine Release Syndrome (CRS) as one of the market
inhibitors venous injection. the dangers which cause corona disease in adults
and pediatric patients (2 years of age and older)
with confirmed diagnosis of covid-19.
Drugs for
treatment of
bone diseases Prefilled syringe Osteoporosis in postmenopausal women and in Available in
– Other drugs Arylia (subcutaneous) 60 mg men at increased risk of fractures. the market
affecting bone
structure and
mineralisation

144